Ankara Yurtsalan Oncology Hospital

Ankara, Turkey

Ankara Yurtsalan Oncology Hospital

Ankara, Turkey

Time filter

Source Type

Aksoy A.,Firat University | Odabas H.,Marmara University | Kaya S.,Marmara University | Bozkurt O.,Erciyes University | And 10 more authors.
Saudi Medical Journal | Year: 2017

Objectives: To analyze the relationship between clinical features, hormonal receptor status, and survival in patients who were diagnosed with medullary breast cancer (MBC). Methods: Demographic characteristics, histopathological features, and survival statuses of 201 patients diagnosed with MBC between 1995 and 2015 were retrospectively recorded. Survival analyses were conducted with uni-and multivariate cox regression analysis. Results: Median follow-up time was 54 (4-272) months. Median patient age at the time of diagnosis was 47 years old (26-90). Of the patients, 91.5% were triple negative. Five-year recurrence free survival time (RFS) rate was 87.4% and overalll survival (OS) rate 95.7%. For RFS, progesterone receptor (PR) negativity, atypical histopathological evaluation, absence of lymphovascular invasion, smaller tumor, lower nodal involvement were found to be favourable prognostic factors by univariate analysis (p<0.05). The PR negativity and smaller tumor were found to be favourable factors by univariate analysis (p<0.05). However, none of these factors were determined as significant independent prognostic factors for OS (p>0.05). Conclusion: Turkish MBC patients exhibited good prognosis, which was comparable with survival outcomes achieved in the literature. The PR negativity was related to a better RFS and OS rates. © 2017, Saudi Arabian Armed Forces Hospital. All rights reserved.

Loading Ankara Yurtsalan Oncology Hospital collaborators
Loading Ankara Yurtsalan Oncology Hospital collaborators